Lyme disease costs healthcare system up to $1.3 billion annually, study finds

Our healthcare system is spending between $712 million and $1.3 billion each year to treat Lyme disease and any lingering illnesses associated with it, say researchers from the Johns Hopkins Bloomberg School of Public Health. The study, “Healthcare Costs, Utilization and Patterns of Care following Lyme disease,” also suggests Lyme disease is more debilitating and widespread than previously thought.

Read More


Canada may see new tick-borne threat: Babesia

Last year, Canadian public health officials and legislators made great strides in recognizing the existence and threat within their country of Borrelia burgdorferi (Bb), the tick-borne organism which causes Lyme disease. Now, there’s evidence that Babesia, a parasite which infects red blood cells and is transmitted primarily through the bite of black-legged ticks, may have reached Canada, as well.

Read More


Reality star Yolanda Foster shines spotlight on Chronic Neurologic Lyme disease

Real Housewives of Beverly Hills star, Yolanda Foster, has made national headlines the past few weeks sharing her most recent struggles with Lyme disease. "Most of you know I have been battling Lyme disease for the past three years. I wasted the first year trying to get diagnosed and spent the next two trying to find a cure,” the 51-year-old former Dutch model writes in her blog. “Unfortunately, I was only able to get to about a 60% recovery until I relapsed in early December and have not been able to find my way back. I’ve lost the ability to read, write…”

Read More


2014 Lyme Review

Major stories for 2014 on Lyme disease and other tick-borne diseases. Covering newly discovered tick-borne pathogens, the spread of existing tick-borne diseases into new geographic regions, an increasing focus on co-infections and legislative and educational efforts to deal with the growing epidemic of Lyme disease.

Read More


Don’t let Scrooge ruin Christmas for Lyme disease patients

Patients suffering with an illness often turn to their doctors for empathy. This is particularly true for those individuals living with chronic, often debilitating, symptoms. An understanding practitioner can play an important role in aiding a patient back to health and impacting clinical outcomes. Yet, according to a study published in this month's issue of Proceedings of the National Academy of Sciences (PNAS), mental health clinicians may actually be less likely to show empathy to their patient if there is an underlying, biological cause behind the illness.

Read More


Senate Unanimously Passes Lyme Disease Act – Canada

OTTAWA - Elizabeth May’s Private Member’s Bill, C-442, the Federal Framework on Lyme Disease Act, was passed unanimously at third reading by the Senate the morning of Friday, December 12. The bill now awaits Royal Assent by the Governor General for it to become law.

Read More


It’s Chronic Fatigue, Not Lyme, infectious disease doc tells Senators

Emotions became heated, at times, during a Senate committee hearing, held last week in Canada, to review proposed legislation that would create a national strategy for Lyme disease. Bill C-442, An Act Respecting a Federal Framework on Lyme Disease, has passed the House of Commons and is now before the Senate.

Read More


Yale study says children don’t have Lyme, but medically unexplained symptoms

I recently came across a video interview featuring Dr. Eugene Shapiro, in which he discusses a study conducted at Yale’s pediatric infectious disease clinic, which found that chronically ill children suspected of having Lyme disease were instead diagnosed with medically unexplained symptoms (MUS).

Read More


A Tribute to Dr. Willy Burgdorfer, discoverer of Lyme spirochete

Some men are born great. Some achieve greatness. And some have greatness thrust upon them. Dr. Willy Burgdorfer at inception was a very great man and by his diligent labors achieved further greatness.

Read More


Canada’s Bill C-442 hopes to create dialogue and federal plan for Lyme disease

In an article entitled "Bill C-442: Shining the limelight on the Lyme-like?" published last week in the Journal of Infectious Diseases & Medical Microbiology, two Canadian physicians express both their support and reservations regarding the bill that has already passed the House of Commons. An Act Respecting a Federal Framework on Lyme Disease, introduced by Member of Parliament Elizabeth May, now awaits a second reading in the Senate. In the interim, Dr. Kevin Laupland and Dr. Louis Valiquette have shared some concerns, which are worthy of addressing. "While we will hope for improvements in the diagnosis of Lyme disease, we are skeptical that major advances will arise as a result of Bill C-442. Accordingly, we believe that a sizable cohort of patients with chronic Lyme-like disease will remain," writes the authors.

Read More